Patent details

EP3256218 Title: A KDM1A INHIBITOR AND ITS USE IN THERAPY

Basic Information

Publication number:
EP3256218
PCT Application Number:
US2016017809
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP167499862
PCT Publication Number:
WO2016130952
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
A KDM1A INHIBITOR AND ITS USE IN THERAPY
French Title of Invention:
UN INHIBITEUR DE KDM1A ET SON UTILISATION EN THÉRAPIE
German Title of Invention:
EIN KDM1A-HEMMER UND SEINE VERWENDUNG IN THERAPIE
SPC Number:

Dates

Filing date:
12/02/2016
Grant date:
11/12/2024
EP Publication Date:
20/12/2017
PCT Publication Date:
18/08/2016
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
11/12/2024
EP B1 Publication Date:
11/12/2024
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
12/02/2036
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
04/12/2024
 
 

Name:
Imago Biosciences Inc.
Address:
2729 Debbie Court, San Carlos, CA 94070, United States (US)

Agent

Name:
MARKS & CLERK LLP
From:
27/01/2025
Address:
BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)
To:

Inventor

1

Name:
MCCALL, John M.
Address:
United States (US)

2

Name:
CELATKA, Cassandra
Address:
United States (US)

3

Name:
RIENHOFF, Hugh Young Jr.
Address:
United States (US)

4

Name:
TAPPER, Amy E.
Address:
United States (US)

5

Name:
CLARE, Michael
Address:
United States (US)

Priority

Priority Number:
201562115474 P
Priority Date:
12/02/2015
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/4192; A61P 35/02; C07C 237/22; C07C 211/35; C07D 249/06;

Publication

European Patent Bulletin

1

Issue number:
202450
Publication date:
11/12/2024
Description:
Grant (B1)

2

Issue number:
202502
Publication date:
08/01/2025
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
02/03/2026
Annual Fee Number:
11
Annual Fee Amount:
148 Euro
Expected Payer:
Last Annual Fee Payment Date:
06/01/2025
Last Annual Fee Paid Number:
10
Last Annual Fee Paid Amount:
131 Euro
Payer:
MARKS & CLERK LLP
Filing date Document type Number of pages
27/01/2025 Power Of Attorney 1
28/01/2025 Outgoing Correspondence 1